Press Release Archive

11.17.2009

Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases

11.17.2009

Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)

11.08.2009

Pfizer Announces Global Research Network

11.04.2009

Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo

11.02.2009

Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease

10.29.2009

Pfizer Completes Consent Solicitation

10.29.2009

Pfizer’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation

10.22.2009

Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend

10.19.2009

Pfizer Reports Third-Quarter 2009 Results

10.19.2009

New Pfizer Animal Health is Unveiled with Acquisition of Wyeth

10.17.2009

CP-690,550, Pfizer’s Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis

10.15.2009

Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture